Universe Pharmaceuticals INC (UPC)
0.1407
-0.0210 (-13.20%)
Inactive · Last trade price
on Nov 15, 2024
UPC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 |
| Revenue | 26.73 | 32.31 | 40.14 | 47.98 | 30.7 | 33.23 | Upgrade
|
| Revenue Growth (YoY) | -22.33% | -19.52% | -16.34% | 56.27% | -7.60% | 16.54% | Upgrade
|
| Cost of Revenue | 19.17 | 21.99 | 18.25 | 22.66 | 16.61 | 19.82 | Upgrade
|
| Gross Profit | 7.56 | 10.32 | 21.89 | 25.33 | 14.09 | 13.41 | Upgrade
|
| Selling, General & Admin | 10.26 | 8.89 | 21.58 | 6.17 | 3.16 | 3.04 | Upgrade
|
| Research & Development | 2.68 | 4.86 | 7.64 | 5.47 | 0.58 | 0.62 | Upgrade
|
| Other Operating Expenses | 0.04 | 0.1 | 0.1 | 0.1 | 0.1 | - | Upgrade
|
| Operating Expenses | 12.97 | 13.84 | 29.33 | 11.74 | 3.84 | 3.65 | Upgrade
|
| Operating Income | -5.42 | -3.53 | -7.44 | 13.59 | 10.25 | 9.75 | Upgrade
|
| Interest Expense | -0.35 | -0.19 | -0.2 | -0.15 | -0.16 | -0.14 | Upgrade
|
| Interest & Investment Income | - | 0.07 | 0.04 | 0.29 | 0.03 | 0.01 | Upgrade
|
| Earnings From Equity Investments | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | -0.24 | 0.05 | -0.08 | -0.05 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -5.83 | -3.85 | -7.51 | 13.68 | 10.1 | 9.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.71 | - | -0.47 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | -0 | -0 | - | -0 | Upgrade
|
| Pretax Income | -16.54 | -3.85 | -7.98 | 13.68 | 10.1 | 9.65 | Upgrade
|
| Income Tax Expense | 2 | 2.31 | 0.75 | 2.36 | 2.54 | 2.1 | Upgrade
|
| Net Income | -18.55 | -6.16 | -8.74 | 11.32 | 7.56 | 7.55 | Upgrade
|
| Net Income to Common | -18.55 | -6.16 | -8.74 | 11.32 | 7.56 | 7.55 | Upgrade
|
| Net Income Growth | - | - | - | 49.77% | 0.09% | -0.68% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 0.29% | - | 14.59% | 18.63% | - | - | Upgrade
|
| EPS (Basic) | -5.10 | -1.70 | -2.41 | 3.58 | 2.83 | 2.83 | Upgrade
|
| EPS (Diluted) | -5.10 | -1.70 | -2.41 | 3.58 | 2.83 | 2.83 | Upgrade
|
| EPS Growth | - | - | - | 26.25% | 0.09% | -0.68% | Upgrade
|
| Free Cash Flow | -6.22 | 1.08 | -1.41 | -15.59 | 6.06 | 13.12 | Upgrade
|
| Free Cash Flow Per Share | -1.71 | 0.30 | -0.39 | -4.93 | 2.27 | 4.92 | Upgrade
|
| Gross Margin | 28.27% | 31.93% | 54.53% | 52.78% | 45.90% | 40.35% | Upgrade
|
| Operating Margin | -20.27% | -10.92% | -18.53% | 28.32% | 33.39% | 29.35% | Upgrade
|
| Profit Margin | -69.40% | -19.08% | -21.76% | 23.59% | 24.62% | 22.73% | Upgrade
|
| Free Cash Flow Margin | -23.27% | 3.33% | -3.50% | -32.49% | 19.75% | 39.48% | Upgrade
|
| EBITDA | -4.92 | -3.02 | -6.9 | 14.04 | 10.66 | 10.17 | Upgrade
|
| EBITDA Margin | -18.40% | -9.34% | -17.20% | 29.25% | 34.72% | 30.61% | Upgrade
|
| D&A For EBITDA | 0.5 | 0.51 | 0.53 | 0.45 | 0.41 | 0.42 | Upgrade
|
| EBIT | -5.42 | -3.53 | -7.44 | 13.59 | 10.25 | 9.75 | Upgrade
|
| EBIT Margin | -20.27% | -10.92% | -18.53% | 28.32% | 33.39% | 29.35% | Upgrade
|
| Effective Tax Rate | - | - | - | 17.24% | 25.17% | 21.77% | Upgrade
|
| Advertising Expenses | - | 4.76 | 17.54 | 1.33 | 0.36 | 0.4 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.